Category:EMA approved in 2017

From HemOnc.org - A Hematology Oncology Wiki

Jump to navigation Jump to search

Pages in category "EMA approved in 2017"

The following 14 pages are in this category, out of 14 total.

A

B

Brigatinib (Alunbrig)

D

Dinutuximab beta (Qarziba)

I

Inotuzumab ozogamicin (Besponsa)

L

Lutetium Lu 177 dotatate (Lutathera)

M

Midostaurin (Rydapt)

N

Niraparib (Zejula)

P

Padeliporfin (Tookad)

R

Rolapitant (Varubi)

T

Retrieved from "https://hemonc.org/w/index.php?title=Category:EMA_approved_in_2017&oldid=73224"

EMA approved drugs